COO · The Cooper Companies, Inc.
$71.022026-07-21Sector: Healthcare; Industry: Medical - Instruments & Supplies; Sub-Industry: Health Care Supplies
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$12
-83.0% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($17 · $9) Analysts Range ($61 · $98) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2024.Q2 | $3.6B | — | 14.8% | 28.5% | $381MM | −$431MM | −$49MM | 7.9% | — | 3.7% | $10.4B | $1.51 | — |
| 2025.Q1 | $3.9B | 8.4% | 18.1% | 32.5% | $476MM | −$666MM | −$190MM | 9.2% | — | 4.5% | $10.6B | $2.01 | — |
| 2025.Q2 | $3.9B | 0.0% | 18.1% | 34.3% | $464MM | −$698MM | −$235MM | 8.3% | — | 4.4% | $10.8B | $2.01 | — |
| 2026.Q1 | $4.1B | 5.1% | 16.7% | 33.7% | $453MM | −$239MM | $213MM | 8.8% | — | 4.2% | $10.7B | $1.92 | — |
| 2026.Q2 | $4.2B | 3.4% | 11.8% | 42.8% | $285MM | −$1MM | $284MM | 8.1% | — | 2.7% | $10.6B | $1.21 | 27.8 |
| italics below = DCF projection · 10yr Rev CAGR: 4.4% |
| 2027.Q2 | $4.4B | +4.3% | 16.7% | 40.5% | $438MM | −$464MM | −$26MM | 8.1% | −$24MM | 4.1% | $11.0B | $2.25 | 31.6 |
| 2028.Q2 | $4.6B | +4.9% | 17.2% | 38.3% | $491MM | −$570MM | −$79MM | 8.1% | −$68MM | 4.3% | $11.6B | $2.52 | 28.2 |
| 2029.Q2 | $4.9B | +5.2% | 17.8% | 36.0% | $556MM | −$644MM | −$88MM | 8.2% | −$70MM | 4.7% | $12.2B | $2.85 | 24.9 |
| 2030.Q2 | $5.1B | +4.6% | 17.8% | 33.7% | $602MM | −$615MM | −$13MM | 8.2% | −$9MM | 4.8% | $12.9B | $3.09 | 23.0 |
| 2031.Q2 | $5.3B | +4.4% | 17.8% | 31.4% | $650MM | −$627MM | $23MM | 8.3% | $15MM | 4.9% | $13.5B | $3.33 | 21.3 |
|
| Term. Yr+ | $6.8B | 4.1% | 16.6% | 20.0% | $905MM | −$431MM | $474MM | 8.6% | $4.7B | 8.6% | — | — | — |
Active scenario IV: $12 (-83.0% vs market)